GlassScriptPhysician profile
Michael A Gioia
NPI 1215459052
$1,055.50
in general payments reported to CMS, 2019-2025
15 companies · $458 in 2025
The $458 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $122 · 2023: $170 · 2024: $172 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $719.52 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $354.80 | 2022-2025 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $139.85 | 2023-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.83 | 2023-2025 | Ofev, Stiolto Respimat, Spiriva |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.86 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $74.30 | 2021-2025 | Zerbaxa |
| Insmed, INC. | $66.58 | 2025 | Arikayce, Brinsupri |
| Glaxosmithkline, LLC. | $44.02 | 2024 | Shingrix, Trelegy Ellipta |
| Genentech USA, INC. | $27.85 | 2025 | Xolair |
| Astrazeneca Pharmaceuticals LP | $25.07 | 2021 | |
| Inogen, INC. | $22.86 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Global Blood Therapeutics, INC. | $21.31 | 2021 | |
| Pfizer INC. | $20.69 | 2021 | |
| United Therapeutics Corporation | $20.67 | 2022 | |
| Ani Pharmaceuticals, INC. | $19.87 | 2025 | Purified Cortrophin Gel |
| Inspire Medical Systems, INC. | $17.94 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gioia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.